000 | 01158 a2200349 4500 | ||
---|---|---|---|
005 | 20250513190807.0 | ||
264 | 0 | _c19991210 | |
008 | 199912s 0 0 eng d | ||
022 | _a0094-6176 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDenninger, M H | |
245 | 0 | 0 |
_aClopidogrel antiplatelet activity is independent of age and presence of atherosclerosis. _h[electronic resource] |
260 |
_bSeminars in thrombosis and hemostasis _c1999 |
||
300 |
_a41-5 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase III; Comparative Study; Journal Article | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAge Factors |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aArteriosclerosis _xblood |
650 | 0 | 4 | _aBleeding Time |
650 | 0 | 4 | _aClopidogrel |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aPlatelet Aggregation _xdrug effects |
650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xadverse effects |
650 | 0 | 4 |
_aTiclopidine _xadverse effects |
700 | 1 | _aNecciari, J | |
700 | 1 | _aSerre-Lacroix, E | |
700 | 1 | _aSissmann, J | |
773 | 0 |
_tSeminars in thrombosis and hemostasis _gvol. 25 Suppl 2 _gp. 41-5 |
|
999 |
_c10398180 _d10398180 |